
Galatea Bio is a biotechnology company focused on advancing healthcare discoveries by leveraging genetic diversity and advanced data analytics. The company operates a CLIA-CMS certified, CAP-accredited high-complexity clinical laboratory and biobank, providing clinical testing and genomic services. It partners with pharmaceutical and life sciences organizations globally to build large-scale population sequencing consortia with academic and health system collaborators. Galatea Bio's platform includes one of the largest private genomic-phenotypic data lakes and a team of population geneticists and bioinformatics experts, enabling the development of new tests, treatments, and cures with a focus on historically underrepresented populations in genetics research. The company emphasizes precision health at scale, combining clinical testing, biopharma R&D, and data science to deliver personalized and equitable healthcare solutions.

Galatea Bio is a biotechnology company focused on advancing healthcare discoveries by leveraging genetic diversity and advanced data analytics. The company operates a CLIA-CMS certified, CAP-accredited high-complexity clinical laboratory and biobank, providing clinical testing and genomic services. It partners with pharmaceutical and life sciences organizations globally to build large-scale population sequencing consortia with academic and health system collaborators. Galatea Bio's platform includes one of the largest private genomic-phenotypic data lakes and a team of population geneticists and bioinformatics experts, enabling the development of new tests, treatments, and cures with a focus on historically underrepresented populations in genetics research. The company emphasizes precision health at scale, combining clinical testing, biopharma R&D, and data science to deliver personalized and equitable healthcare solutions.